HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

PrEP concept | Image credit: wladimir1804 - stock.adobe.com
Dynamic Choice HIV Prevention Could Lead to Reduced Incidence

September 16th 2025

A reduction in HIV incidence is possible with more structured choices for pre-exposure and postexposure prophylaxis being offered to patients at risk of HIV.

Man rubbing wrist | Image credit: pikselstock - stock.adobe.com
Individuals With HIV Have an Increased Risk of Osteoporosis

September 11th 2025

Blood donation | Image credit: New Africa - stock.adobe.com
Overall Incidence of HIV in Donated Blood Declined Despite Reduction in Deferral Periods

September 8th 2025

Molecular structure of INSTI | Image credit: Сергей Шиманович - stock.adobe.com
ACC017 Showed Safety, Tolerability When Used as Antiretroviral Therapy

September 4th 2025

HIV test | Image credit: gamjai - stock.adobe.com
Cotesting for HIV, STIs Improved Screening Practices for HIV

September 2nd 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
September 17th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
September 17th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Launch of Highly Efficacious HIV, Tuberculosis, and Malaria Vaccines Unlikely, Study Says
September 18th 2018

Launch of Highly Efficacious HIV, Tuberculosis, and Malaria Vaccines Unlikely, Study Says

Jaime Rosenberg
Researchers determined that the current drug pipeline is unlikely to produce any highly effective vaccines for HIV, tuberculosis, or malaria, which could be important for controlling the spread of these diseases.
Medication Adherence Program for HIV Needs Collaboration Among Physicians, Nurses, and Pharmacists
September 15th 2018

Medication Adherence Program for HIV Needs Collaboration Among Physicians, Nurses, and Pharmacists

David Bai
A descriptive, observational study in Switzerland implemented an interprofessional medication adherence program (IMAP) in patients with HIV. The framework for the implementation of services in pharmacy (FISpH) model is described and formulated for other healthcare facilities and professionals to evaluate and execute for themselves.
AJMC® in the Press, September 14, 2018
September 14th 2018

AJMC® in the Press, September 14, 2018

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
California Medicaid Expansion Had Mixed Effects for HIV Population
September 11th 2018

California Medicaid Expansion Had Mixed Effects for HIV Population

Jaime Rosenberg
With the expansion of Medicaid, eligible, low-income people living with HIV were transferred from the Ryan White Program to Medicaid, causing concern for interrupted access to care and treatment.
HIV/AIDS Research Has Positive Impacts Across Other Medical Fields
September 6th 2018

HIV/AIDS Research Has Positive Impacts Across Other Medical Fields

Jaime Rosenberg
In addition to the advances made in the HIV space, such as antiretroviral therapies and pre-exposure prophylaxis, the years of research has translated into advances outside the HIV field, including in oncology and other immune diseases.
Report: States Can Improve HIV Care Through Medicaid, Ryan White Program Collaboration
September 6th 2018

Report: States Can Improve HIV Care Through Medicaid, Ryan White Program Collaboration

Jaime Rosenberg
In a 3-part series, the National Academy for State Health Policy explored how states can use policy levers to more effectively utilize limited resources and provide better care, improve care coordination services, and ensure consistent access to care for people living with HIV.
Closing Treatment Gaps Critical for Ending HIV Epidemic in United States
August 30th 2018

Closing Treatment Gaps Critical for Ending HIV Epidemic in United States

Jaime Rosenberg
Targeted treatment interventions for populations with low levels of viral suppression, paired with tailored prevention packages, will be essential to ending the HIV epidemic in the United States, say researchers.
Patients With HIV Will Forgo Short Wait Time, Travel Distance to Access Nice Providers
August 28th 2018

Patients With HIV Will Forgo Short Wait Time, Travel Distance to Access Nice Providers

Jaime Rosenberg
Patients with HIV indicated a strong preference for “nice” over “rude” providers and a willingness to wait 19 hours more or travel 28 miles farther to see nice rather than rude providers.
PrEP for HIV Serves as Gateway to Primary Care
August 24th 2018

PrEP for HIV Serves as Gateway to Primary Care

Jaime Rosenberg
Researchers found that pre-exposure prophylaxis (PrEP) usage is linked to routine care, such as influenza vaccination, tobacco and depression screening, and glucose testing.
Between 1997 and 2015, Viral Suppression Rates Nearly Tripled in People Living With HIV
August 21st 2018

Between 1997 and 2015, Viral Suppression Rates Nearly Tripled in People Living With HIV

Jaime Rosenberg
The emergence and uptake of antiretroviral therapy (ART) has led to significant improvements in viral suppression rates over the past 2 decades.
Site Logo
August 16th 2018

Impact of a Medical Home Model on Costs and Utilization Among Comorbid HIV-Positive Medicaid Patients

Paul Crits-Christoph, PhD Robert Gallop, PhD Elizabeth Noll, PhD Aileen Rothbard, ScD Caroline K. Diehl, BS Mary Beth Connolly Gibbons, PhD Robert Gross, MD, MSCE Karin V. Rhodes, MD, MS
Among HIV-positive Medicaid patients with comorbid medical and psychiatric disorders, there was increased outpatient service utilization, yet relative cost savings, for patients who were treated in patient-centered medical homes.
Putting AIDS 2018 Into Perspective: Policy, Advocacy Implications
August 15th 2018

Putting AIDS 2018 Into Perspective: Policy, Advocacy Implications

Jaime Rosenberg
Contrasting the excitement and optimism coming out of clinical research presented at the AIDS 2018 conference, there was a sobering takeaway in the political and advocacy sphere. Among the general consensus that we are in a fragile moment in time, there were several policies and advocacy efforts that made it to the forefront of the conference.
Putting AIDS 2018 Into Perspective: Clinical Implications
August 14th 2018

Putting AIDS 2018 Into Perspective: Clinical Implications

Jaime Rosenberg
The 2018 International AIDS Conference in Amsterdam brought a plethora of new clinical implications for HIV care, reflecting ongoing investments in research efforts and optimism across all clinical domains, including vaccines, prevention, and new treatment approaches. However, with the excitement also came caution in other areas, such as stagnant incidence rates.
Individuals With HIV Are Twice as Likely to Develop Cardiovascular Disease, Study Finds
August 11th 2018

Individuals With HIV Are Twice as Likely to Develop Cardiovascular Disease, Study Finds

Alison Rodriguez
People living with HIV are twice as likely to develop cardiovascular disease and the global burden of HIV associated with cardiovascular disease has tripled over the last 2 decades.
Janssen Releases New Data Confirming Safety and Efficacy of Symtuza for HIV
August 9th 2018

Janssen Releases New Data Confirming Safety and Efficacy of Symtuza for HIV

Jaime Rosenberg
A month after Symtuza's approval, Janssen announced new switch data on the treatment and a second study supporting its use in a rapid initiation scenario.
PEPFAR, Elton John Reaffirm Commitment to, Investment in HIV Support for Key Populations
August 3rd 2018

PEPFAR, Elton John Reaffirm Commitment to, Investment in HIV Support for Key Populations

Jaime Rosenberg
During the 2018 International AIDS Conference, the US President’s Emergency Plan for AIDS Relief (PEPFAR) and the Elton John AIDS Foundation revealed initial results from the LGBT Fund, which they launched in 2016. PEPFAR also announced over $360 million in funding over the next 12 months.
Neurological Disabilities More Likely in Children With HIV
August 2nd 2018

Neurological Disabilities More Likely in Children With HIV

Jaime Rosenberg
Developmental issues, such as impaired brain growth, are more likely to occur in children with HIV than those without the virus.
Podcast: This Week in Managed Care—CMS to Resume Risk Adjustment Payments and Other Health News
July 28th 2018

Podcast: This Week in Managed Care—CMS to Resume Risk Adjustment Payments and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: July 27, 2018
July 27th 2018

This Week in Managed Care: July 27, 2018

This week, the top managed care stories included CMS reversing its decision to suspend the risk adjustment payment program; out-of-pocket costs and copayment accumulators put an HIV prevention drug out of reach for patients; research finds geography can determine posttreatment imaging for women with breast cancer.
HIV Comorbidities Associated With More Hospitalizations, Increased Costs
July 26th 2018

HIV Comorbidities Associated With More Hospitalizations, Increased Costs

Jaime Rosenberg
As people living with HIV now have a normal life expectancy, thanks to antiretroviral therapy, the burden of comorbidities is on the rise, and more than half of deaths in the patient population are attributable to these comorbidities.
PrEP for HIV Prevention: Essential for Ending the Epidemic, but Out of Reach for Many
July 24th 2018

PrEP for HIV Prevention: Essential for Ending the Epidemic, but Out of Reach for Many

Jaime Rosenberg
Despite pre-exposure prophylaxis (PrEP) being crucial for preventing new HIV infections and working toward an end to the epidemic, the treatment is still out of reach for many.
Urgent Change in Approach to HIV Pandemic Is Needed, Report Says
July 20th 2018

Urgent Change in Approach to HIV Pandemic Is Needed, Report Says

Jaime Rosenberg
According to a report, existing HIV tools and strategies are insufficient, and despite historic breakthroughs in maximizing prevention and treatment strategies, the HIV pandemic will likely continue to be a global challenge for the foreseeable future.
FDA Approves First Darunavir-Based Single-Tablet Regimen for HIV
July 18th 2018

FDA Approves First Darunavir-Based Single-Tablet Regimen for HIV

Jaime Rosenberg
Janssen announced the approval of Symtuza (darunavir 800 mg, cobistat 150 mg, emtricitabine 200 mg, and tenofovir alafenamide 10 mg) for the treatment of HIV-1 in treatment-naïve and certain virologically suppressed patients.
MANNA: Providing Nutritious Meals and a Sense of Community to People Living With HIV
July 13th 2018

MANNA: Providing Nutritious Meals and a Sense of Community to People Living With HIV

Jaime Rosenberg
Since 1990, MANNA has been providing nourishing meals and a sense of community to people living with HIV and other chronic diseases in Philadelphia.
Site Logo
July 13th 2018

Modeling the Impacts of Restrictive Formularies on Patients With HIV

James Baumgardner, PhD Caroline Huber, MPH Mina Kabiri, PhD Lara Yoon, MPH Jacki Chou, MPP, MPL John Romley, PhD
Constraining access to HIV regimens can have significant implications for patients. This study examined the economic and health impacts of restrictive HIV formulary designs.
Mobile Health Intervention for HIV Improves Retention in Care, Patient Outcomes
July 11th 2018

Mobile Health Intervention for HIV Improves Retention in Care, Patient Outcomes

Jaime Rosenberg
Through the use of a smartphone app, researchers observed that participants became more engaged with their HIV care, resulting in improved linkage to and consistency of care, increased CD4 counts, and decreased viral loads.
HIV Vaccine Candidate Proves Safe, Induces Immune Response in Healthy Adults, Monkeys
July 7th 2018

HIV Vaccine Candidate Proves Safe, Induces Immune Response in Healthy Adults, Monkeys

Jaime Rosenberg
Research results from 2 studies found that the mosaic Ad26–based HIV vaccine regimens were both well-tolerated and induced a robust immune response against HIV in healthy adults and rhesus monkeys.
This Week in Managed Care: July 6, 2018
July 6th 2018

This Week in Managed Care: July 6, 2018

This week, the top managed care stories included a federal judge blocking Kentucky’s Medicaid work requirements; CMS announced it would launch a demonstration to encourage Medicare Advantage providers to take on more risk; and researchers identify racial disparities in HIV incidence and recommended a 5-part plan of action.
Site Logo
July 5th 2018

Study Summary: Impact of Same-Day HIV Testing and ART Initiation on Patient Care and Outcomes

Koenig SP, Dorvil N, D
Site Logo
July 5th 2018

Study Summary: Effect of Comorbid MDD on HIV Disease Profression

Owora AH. Major depression disorder trajectories, HIV disease progression: results from a 6-year outpatient clinic cohort. Medicine (Baltimore). 2018, 97(12):e0252. doi: 10.1097/MD.0000000000010252.
<1
...
222324252627282930
...
33>

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo